Researchers develop test to measure effect of breast cancer gene variants

COVID-19 vaccine candidate, tested at UAB, will start Phase 1 clinical trial
19 February 2021
New Zealand says COVID vaccinations ‘small step in long journey’
20 February 2021

Researchers develop test to measure effect of breast cancer gene variants

Researchers at Mayo Clinic have combined results from a functional test measuring the effect of inherited variants in the BRCA2 breast and ovarian cancer gene with clinical information from women who received genetic testing to determine the clinical importance of many BRCA2 variants of uncertain significance (VUS). The findings were published today in a study in the American Journal of Human Genetics.

Comments are closed.